Top 20 Highest-Grossing Rock And Pop Tours Of 2017; U2, Guns N’ Roses, Coldplay, and Bruno Mars Tops
Irish band U2 topped the list with the band’s massive 30th anniversary tour for The Joshua Tree album, which raked in $316 million, according to Pollstar’s top 20 worldwide tours of 2017. Guns N’ Roses came in a close 2nd, pulling $292.5 million with 2.68 million tickets sold.
British band Coldplay took 3rd place with $238 million, followed by Bruno Mars, who pulled into the 4th slot with $200.1 million in ticket revenues for 2017.
In 11th place, my favourite, Celine Dion was the highest-ranking female artist on the list, pulling in $101.2 million
Top 20 worldwide tours of 2017:
- U2, 316 million
- Guns N’ Roses, $292.5 million
- Coldplay, $238 million
- Bruno Mars, $200.1 million
- Metallica, $152.8 million
- Depeche Mode, $141.1 million
- Paul McCartney, $132 million
- Ed Sheeran, $124.1 million
- The Rolling Stones, $120 million
- Garth Brooks, $101.4 million
- Celine Dion, $101.2 million
- Justin Bieber, $93.7 million
- Roger Waters, $92.1 million
- Bruce Springsteen, $87.8 million
- Lady Gaga, $85.7 million
- Billy Joel, $82.3 million
- The Weeknd, $80 million
- Tim McGraw / Faith Hill, $79.3 million
- Red Hot Chili Peppers, $73.5 million
- Ariana Grande, $99.2 million
Top 20 worldwide tours of 2017 [Infographic ]
Add CEOWORLD magazine to your Google News feed.
Follow CEOWORLD magazine headlines on: Google News, LinkedIn, Twitter, and Facebook.
This report/news/ranking/statistics has been prepared only for general guidance on matters of interest and does not constitute professional advice. You should not act upon the information contained in this publication without obtaining specific professional advice. No representation or warranty (express or implied) is given as to the accuracy or completeness of the information contained in this publication, and, to the extent permitted by law, CEOWORLD magazine does not accept or assume any liability, responsibility or duty of care for any consequences of you or anyone else acting, or refraining to act, in reliance on the information contained in this publication or for any decision based on it.
Copyright 2024 The CEOWORLD magazine. All rights reserved. This material (and any extract from it) must not be copied, redistributed or placed on any website, without CEOWORLD magazine' prior written consent. For media queries, please contact: info@ceoworld.biz
SUBSCRIBE NEWSLETTER
